HomeXENE • NASDAQ
add
Xenon Pharmaceuticals Inc
Previous close
$39.55
Day range
$37.60 - $39.11
Year range
$35.53 - $50.99
Market cap
2.93B USD
Avg Volume
384.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.71M | 30.47% |
Net income | -62.79M | -29.57% |
Net profit margin | — | — |
Earnings per share | -0.81 | -10.96% |
EBITDA | -73.01M | -35.32% |
Effective tax rate | 0.51% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 654.02M | 24.18% |
Total assets | 835.90M | 24.56% |
Total liabilities | 38.09M | 10.41% |
Total equity | 797.81M | — |
Shares outstanding | 76.24M | — |
Price to book | 3.76 | — |
Return on assets | -21.42% | — |
Return on capital | -22.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -62.79M | -29.57% |
Cash from operations | -51.15M | -6.38% |
Cash from investing | 1.98M | -96.33% |
Cash from financing | — | — |
Net change in cash | -49.11M | -240.23% |
Free cash flow | -46.66M | -26.03% |
About
Founded
1996
Headquarters
Website
Employees
255
